Kura Oncology is a clinical stage biopharmaceutical company focused on the discovery and development of precision medicines for the treatment of solid tumors and blood cancers. Kura s pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. The company s lead drug candidate is tipifarnib, a farnesyl transferase inhibitor. The company s preclinical pipeline includes KO , an ERK inhibitor, and a menin MLL inhibitor program.
Quote | Kura Oncology Inc. (NASDAQ:KURA)
Last: | $13.29 |
---|---|
Change Percent: | -2.99% |
Open: | $13.7 |
Close: | $13.70 |
High: | $13.7 |
Low: | $13.241 |
Volume: | 33,890 |
Last Trade Date Time: | 06/09/2023 03:00:00 am |
News | Kura Oncology Inc. (NASDAQ:KURA)
– Late-breaking abstracts scheduled for publication on the EHA website at 16:00 CET on Thursday, June 1, 2023 – – Data from Phase 1 trial of ziftomenib to be presented at the late-breaking oral session on Sunday, June 11, 2023 – – Management to host vi...
2023-05-25 16:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Kura Oncology Inc. (NASDAQ:KURA)
Subject | By | Source | When |
---|---|---|---|
* * $KURA Video Chart 04-28-2020 * * | ClayTrader | investorshub | 04/28/2020 9:04:32 PM |
Anybody out there? ! | seppi08162 | investorshub | 12/19/2019 5:52:35 PM |
KURA buy 19.00 | stocktrademan | investorshub | 02/11/2018 5:50:43 PM |
Feels risky here...feels like they're purposely notching it | Lone Wolf | investorshub | 09/08/2017 3:17:02 PM |
Looks like the markets are really starting to | Lone Wolf | investorshub | 09/08/2017 2:26:26 PM |
News, Short Squeeze, Breakout and More Instantly...